Diminished ovarian reserve in young women with sickle cell anemia
- PMID: 34864892
- PMCID: PMC8854680
- DOI: 10.1182/blood.2021012756
Diminished ovarian reserve in young women with sickle cell anemia
Abstract
Women with sickle cell anemia (SCA) have higher rates of diminished ovarian reserve (DOR) than age-matched controls. Pecker et al report a small study of patients with SCA that compares ovarian reserve in patients after stem cell transplant, on therapy with hydroxyurea (HU), and on supportive care. As expected, patients who received transplants have severe DOR. About one-third of patients on HU have DOR, while DOR was absent in patients on supportive care. Whether this reflects an impact of HU or is a biomarker of severe disease remains to be established in a larger study.
Comment in
-
Reproductive equity: preserve the reserve.Blood. 2022 Feb 17;139(7):963-965. doi: 10.1182/blood.2021015021. Blood. 2022. PMID: 35175326 No abstract available.
-
Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility.Blood Adv. 2023 Sep 12;7(17):4794-4798. doi: 10.1182/bloodadvances.2022008859. Blood Adv. 2023. PMID: 36989137 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
